Health Catalyst (HCAT) awards 80,691 restricted stock units to company director

Rhea-AI Filing Summary

Health Catalyst, Inc. director Jill Hoggard Green reported the acquisition of 80,691 restricted stock units (RSUs) of common stock as a compensation award under the company’s 2019 Stock Option and Incentive Plan.

Each RSU represents one share of common stock and will fully vest on the earlier of the one-year anniversary of the grant date or the next Annual Meeting of Stockholders. Following this award, she beneficially owns 144,628 shares of common stock.

Insider Trade Summary

Net Buyer: 80,691 shares

Net Buy 1 txn

Insider Hoggard Green Jill

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Common Stock F1	80,691	$0.00	$0.00

Holdings After Transaction: Common Stock — 144,628 shares (Direct)

Footnotes (1)

1. F1. Represents an award of restricted stock units ("RSUs") granted pursuant to the Issuer's 2019 Stock Option and Incentive Plan (the "2019 Plan"). Each RSU represents a contingent right to receive one share of the Issuer's common stock. Subject to the terms of the 2019 Plan, the RSUs will fully vest on the earlier of (i) the one-year anniversary of the grant date or (ii) the date of the next Annual Meeting of the Issuer's Stockholders.

Key Figures

RSUs granted: 80691.0000 shares Grant price per RSU: 0.0000 per share Shares owned after grant: 144628.0000 shares +1 more

4 metrics

RSUs granted 80691.0000 shares Restricted stock units awarded to director on 2026-07-16

Grant price per RSU 0.0000 per share Reported per-share value for compensation RSU award

Shares owned after grant 144628.0000 shares Beneficial ownership of common stock following the RSU award

Vesting trigger 1 year or next Annual Meeting RSUs vest on the earlier of one-year anniversary or next Annual Meeting

Key Terms

restricted stock units ("RSUs"), 2019 Stock Option and Incentive Plan, Annual Meeting of the Issuer's Stockholders

3 terms

restricted stock units ("RSUs") financial

"Represents an award of restricted stock units ("RSUs") granted pursuant to the Issuer's 2019"

Restricted stock units (RSUs) are a company promise to give an employee shares of stock (or cash equivalent) in the future, but only after certain conditions—usually staying with the company for a set time or hitting performance goals—are met. Investors watch RSUs because when they vest they increase the number of shares outstanding and can lead insiders to sell shares, affecting share price, company dilution and the true cost of employee pay.

2019 Stock Option and Incentive Plan financial

"RSUs granted pursuant to the Issuer's 2019 Stock Option and Incentive Plan (the "2019 Plan")"

Annual Meeting of the Issuer's Stockholders financial

"vest on the earlier of (i) the one-year anniversary or (ii) the date of the next Annual Meeting"

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Form 4 Insider Transactions: What Each Field Means →

Available on EDGAR 07/20/2026 - 05:19 PM Accepted by SEC EDGAR 07/20/2026 - 05:19 PM Learn about SEC filing dates

FAQ

What did the latest Form 4 for Health Catalyst (HCAT) report for Jill Hoggard Green?

The Form 4 reports that director Jill Hoggard Green received an award of 80,691 restricted stock units (RSUs) of Health Catalyst common stock as compensation under the company’s 2019 Stock Option and Incentive Plan.

How many Health Catalyst (HCAT) shares does Jill Hoggard Green own after this RSU grant?

After the reported RSU award, Jill Hoggard Green is shown as beneficially owning 144,628 shares of Health Catalyst common stock. This figure reflects her holdings immediately following the 80,691 RSU grant disclosed in the Form 4.

When will Jill Hoggard Green’s new RSUs in Health Catalyst (HCAT) vest?

The 80,691 RSUs will fully vest on the earlier of one year from the grant date or the date of Health Catalyst’s next Annual Meeting of Stockholders, subject to the terms and conditions of the company’s 2019 Stock Option and Incentive Plan.

What is the purchase price for Jill Hoggard Green’s RSU grant in Health Catalyst (HCAT)?

The RSU award was reported with a per-share price of $0.0000, reflecting that it is a compensation grant rather than a market purchase. Each restricted stock unit represents a contingent right to receive one share of common stock at vesting.

Was Jill Hoggard Green’s RSU transaction in Health Catalyst (HCAT) under a Rule 10b5-1 plan?

The filing’s Rule 10b5-1 checkbox was not marked as being pursuant to a trading plan, indicating this reported RSU grant was not designated as a Rule 10b5-1 pre-arranged trading arrangement in the Form 4 data.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Hoggard Green Jill

(Last) (First) (Middle)

C/O HEALTH CATALYST, INC.

10897 SOUTH RIVER FRONT PARKWAY, #300

(Street)

SOUTH JORDAN UTAH 84095

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Health Catalyst, Inc. [ HCAT ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
07/16/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	07/16/2026		A		80,691(1)	A	$0.00	144,628	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Represents an award of restricted stock units ("RSUs") granted pursuant to the Issuer's 2019 Stock Option and Incentive Plan (the "2019 Plan"). Each RSU represents a contingent right to receive one share of the Issuer's common stock. Subject to the terms of the 2019 Plan, the RSUs will fully vest on the earlier of (i) the one-year anniversary of the grant date or (ii) the date of the next Annual Meeting of the Issuer's Stockholders.

Remarks:

	/s/ Benjamin Landry, as Attorney-in-Fact	07/20/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)